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Background & objectives: The dual epidemic of HIV and tuberculosis is a cause for concern in those
countries where these two infections are prevalent in epidemic proportions. We undertook a survey at
two sites in North Arcot district of Tamil Nadu in 1992-1993, to know the seroprevalence of HIV
infection among tuberculosis patients. The objective of this study was to re-examine the prevalence of
HIV infection among tuberculosis patients in a repeat survey.
Methods: The study  was undertaken in four centres: District Tuberculosis Centre (DTC), Vellore,
Tuberculosis Sanatorium, Pennathur (Vellore), District TB Centre (DTC), Kancheepuram and the
Government Thiruvotteswarar Tuberculosis Hospital (GTTH), Chennai in the northern part of
Tamil Nadu during 1997-1998. A total of 2361 newly diagnosed TB patients were registered in this
study. HIV serology after pre-test counseling was done along with sputum examination for acid-fast
bacillus by smear and culture for mycobacteria for all patients.
Results: The overall HIV seroprevalence among TB patients was 4.7 per cent. The highest HIV
seropositivity rate was found among patients aged 30-39 yr (10.6%). HIV seroprevalence showed a wide
variation among the different centres ranging from 0.6. per cent in DTC, Kancheepuram to
9.4 per cent in Pennathur Sanatorium, Vellore. Sputum smear positivity was 88 per cent among the
HIV-negative and 83 per cent among HIV-positive tuberculosis patients.
Interpretation & conclusion: HIV  infection is on the rise among TB patients in Tamil Nadu. Acid-fast
smear microscopy is adequate for the diagnosis of pulmonary tuberculosis, and drug resistance among
HIV positive patients is not a major problem at this point of time; hence antituberculosis regimens
recommended by the Revised National  Tuberculosis Control Program (RNTCP) can be used to treat
HIV positive patients with tuberculosis.
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The advancing epidemic of infection with human
immunodeficiency virus (HIV) has increased the
burden of tuberculosis, especially in populations where
HIV has become common, and where the prevalence
of tuberculosis infection is high. It is estimated that
worldwide, nearly two billion people are infected with
Mycobacterium tuberculosis, 40 million are HIV-
infected and over 10 million are dually infected with
M.tuberculosis and HIV1,2.
Infection with HIV is the most potent known risk
factor for progression of active tuberculosis. HIV-
seronegative individuals infected with M.tuberculosis
have an approximately 10 per cent lifetime risk of
developing active tuberculosis, compared with a
60 per cent or more risk in persons infected with both
HIV and M. tuberculosis3.
The number of HIV-infected individuals in India is
estimated to be 3.9 million4. Tuberculosis is the
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commonest opportunistic infection occurring among
HIV-positive individuals in India and it is estimated that
60-70 per cent of HIV-positive patients will develop
tuberculosis in their lifetime5,6. Studies from different
parts of the country have reported both low (0.4-4.7%)7,8
and high HIV seroprevalence rates (10-24%)9-14  among
tuberculosis patients.
Among the Indian states, Tamil Nadu and
Maharashtra have the highest documented number of
HIV and AIDS cases15. Sentinel surveillance has been
carried out among the various high risk groups
periodically. The Tuberculosis Research Centre
(TRC),Chennai had undertaken a survey in 1992-1993
at two sites in North Arcot district of Tamil Nadu to
study the seroprevalence of HIV among patients with
newly diagnosed tuberculosis16. A repeat survey was
undertaken in 1997-1998 in the four centres
(including the two previous sites in North Arcot district )
to study the change in HIV prevalence among
tuberculosis patients.
Material & Methods
Four centres selected for the study were District
Tuberculosis Centre (DTC), Vellore (Urban), Pennathur
Sanatorium Vellore (Rural), District Tuberculosis Centre,
Kancheepuram (semi-urban) and the Government
Thiruvotteswarar Tuberculosis Hospital (GTTH),
Chennai (Metropolitan). Consecutive patients attending
these centres during the period from July 1997 to
June 1998 with a diagnosis of tuberculosis were
registered for the study. All patients were residents of
the northern part of Tamil Nadu.
The patients were questioned regarding their
symptoms and signs and given pre-test counseling. The
medical officers of the TB clinics made the diagnosis of
tuberculosis based on clinical, radiological and
bacteriological findings. Blood sample for HIV serology
(2 ml) and two sputum specimens were collected from
each patient. Appropriate treatment was given for
pulmonary and extrapulmonary tuberculosis. Post-test
counseling was done and patients were referred to the
nearest district headquarters hospital for special
investigations and management as required. The study
was approved by the Ethical Committee of the
Tuberculosis Research Centre.
The blood and sputum specimens were transported
to TRC, Chennai for further testing. The sputum smears
were examined for  acid-fast bacillus (AFB) by
fluorescent microscopy. The sputum samples were
processed by the Petroff's method17, cultured on the
Lowenstein-Jensen medium (LJ, prepared at the
bacteriology lab, TRC) and examined weekly up to
8 wk for growth. The positive cultures were subjected
to identification tests, viz. niacin production, growth in
LJ medium containing 500mg/l of para nitro benzoic acid
and stability at 68ºC in order to identify the organism as
M.tuberculosis or non-tuberculous mycobacteria18. All
the isolates of M.tuberculosis isolated from HIV positive
patients were subjected to drug susceptibility testing using
standard methods18. HIV infection was diagnosed by
performing two ELISA tests with two different kits
according to the WHO recommendation for developing
countries19. The samples were tested using the TRIDOT
rapid test (J Mitra, New Delhi, India) and those found
positive were confirmed using routine ELISA (Lab
Systems, India). The data were statistically analysed by
the Chi-square test.
Results
A total of 2361 patients (1682 males, 679 females)
with newly diagnosed tuberculosis were registered for
the study. Of them, 111 were seropositive, giving an
overall prevalence of HIV among newly diagnosed
tuberculosis patients in these centres as 4.7 per cent.
The seroprevalence rates at the four centres showed
wide variation ranging from 0.6 per cent (4/613) in DTC
Kancheepuram, 4.0 per cent (22/545) in GTTH, Chennai,
4.3 per cent (23/540) in DTC, Vellore and 9.4 per cent
(62/663) in Pennathur Sanatorium, Vellore. The
prevalence of HIV infection was 6 per cent in patients
aged 20-29 yr, reached a peak of 10.6 per cent at
30-39 yr and thereafter decreased to 1.2 per cent in the
≥50 yr age group (Table). It was higher in males in most
age groups, but the difference between the sexes was
statistically significant only in the age group of 30-39 yr
(P<0.005).
Of the total 2361 patients, 1048 (44%) were new
smear positive TB patients, 905 (38%) were X-ray
positive smear negative patients and 133 (5.6%) were
extrapulmonary  tuberculosis patients. Of the 1323
patients initially categorized as new smear positives 275
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were smear negative on subsequent examination at
TRC, Chennai  and were excluded from further analysis.
Sixty eight (6.5%) of new smear positive patients,
39(4.3%) X-ray positive smear negative patients and
4(3.0%) extra-pulmonary TB patients were found to be
HIV seropositive. Of the 1184 cultre positive patients,
59 (5%) were HIV positive. There was no difference in
the proportion of smear positivity between the culture
confirmed HIV positive (83%) and HIV negative (88%)
tuberculosis patients.
Anti tubercular drug susceptibility testing was done
only on the 59 isolates obtained from the 111 HIV positive
TB patients. Isoniazid (H) resistance was observed in
7 (12%), and rifampicin (R) was noted in 3 (5%) isolates
which were also resistant  to H.
Discussion
We found that HIV seroprevalence rates among
tuberculosis patients were similar in males (4.9%) and
females (4.1%) and were highest in the age-group
30-39 yr (10.6%). Our data suggest that it is better to
target tuberculosis patients aged between 20-49 yr for
HIV screening, as 92 per cent of the cases were found
in this age group.
The seroprevalence of HIV among TB patients showed
wide variations between the different centres where the
survey was undertaken. The prevalence in DTC, Vellore
and GTT hospital, Chennai was 4.3 and 4.0 per cent
respectively compared to 0.6 per cent in DTC,
Kancheepuram; this could be due to the fact  that most
patients suspected to be HIV positive from Kancheepuram
seek  medical attention at Tambaram Sanatorium, Chennai,
which is geographically close. In our previous survey16,
4 per cent of TB patients were HIV seropositive in DTC,
Vellore and 2 per cent in Pennathur Sanatorium. In the
present survey the highest rate was recorded in Pennathur
Sanatorium, where it has increased from 2.0 per cent in
1992-1993  to 9.4 per cent in 1997-1998. This marked
increase in HIV seroprevalence in this centre is statistically
significant (P<0.001) compared to DTC, Vellore where it
has marginally increased to 4.3 per cent from 4 per cent
in 1992-1993, and could be attributed to the fact that the
government has identified TB sanatoria and STD clinics
all over Tamil Nadu as centres for comprehensive HIV
care (HIV/TB and other opportunistic infections).
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Table. HIV seroprevalence among tuberculosis patients in Tamil Nadu by age, sex & type of institution
Males Females Both sexes
Total HIV Positives Total HIV Positives Total HIV Positives
No. % No. % No. %
Age (yr)
<20 89 0 0 101 1 0.9 190 1 0.5
20-29 264 17 6.4 210 11 6.0 474 28 6.0
30-39 360 45 12.5* 168 11 6.6 528 56 10.6
40-49 426 15 3.5 98 3 3.1 524 18 3.4
≥50 543 6 1.1 102 2 1.9 645 8 1.2
Centres
GTTH, Chennai 445 19 4.2 100 3 3.0 545 22 4.0
DTC, Kancheepuram 404 2 0.5 209 2 0.9 613 4 0.6
DTC, Vellore 379 14 3.7 161 9 5.6 540 23 4.3
Pennathur Sanatorium, Vellore 454 48 10.6 209 14 6.7 663 62 9.4†
Total 1682 83 4.9 679 28 4.1 2361 111 4.7
*P<0.05 compared to females; †P<0.001 compared to DTC Kancheepuram; DTC, District Tuberculosis Centre; GTTH, Government
Thiruvotteswarar Tuberculosis Hospital
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The higher HIV seroprevalence rate in Pennathur
Sanatorium is also reflected in other studies among STD
clinic attendees in the same area20 and in Pondicherry21.
Rajasekaran et al22 reported an increase in HIV
seroprevalence from 0.59 per cent in 1996 to
8.9 per cent in 1999 among TB patients in rural Tamil
Nadu. These studies indicate that HIV seroprevalence
among various high-risk groups is increasing in Tamil Nadu.
Another important finding of our study was that
positive smears were obtained in similar proportions of
HIV positive and negative, culture confirmed cases of
tuberculosis. Our data confirm the findings of
Smith et al23 who observed no differences in the
frequency of positive smears between HIV-infected and
not-infected individuals. This suggests that sputum smear
microscopy is a useful test for diagnosis of tuberculosis
in the TB control program.
A limitation of this study was that information on the
stage of HIV infection was not available; hence it was
not possibe to correlate the degree of immunosuppression
with sputum smear positivity. However, as most of these
patients were ambulatory and attending outpatient clinics
(except for a small number among those attending the
sanatorium),it is likely that they did not have advanced
HIV infection or AIDS. It is well known that tuberculosis
occurs in all stages of HIV disease and tuberculosis need
not be considered an AIDS defining illness in disease
endemic countries as it also has a better prognosis than
other AIDS-defining illnesses24.
Our study underlines the fact that M.tuberculosis is
the predominant pathogen among the HIV positive TB
patients as none of the culture isolates was identified as
non-tuberculous mycobacteria (NTM). The pattern of
drug  resistance among the HIV positive patients in the
present study  was found to be similar to that  found
among the HIV-negative population in this part of
Tamil Nadu25. Hence, HIV positive patients with
tuberculosis can be treated with standard antituberculosis
regimens recommended and employed in the Revised
National Tuberculosis Control Program (RNTCP)26.Our
findings show wide variations in the HIV seroprevalence
among the TB patients from the three different districts
of northern Tamil Nadu, as the  percentage of HIV
prevalence is likely to be higher in tertiary care centres
and lower in peripheral and district hospitals.
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